REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmacos Centrales Globales S.A. DE C.V. (Mexico)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmacos Centrales Globales S.A. DE C.V. Profile Updated: December 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farmacos Centrales Globales S.A. DE C.V. is a company based in Mexico, with its head office in Queretaro. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on November 11, 2014. It currently has a total number of 2 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 10.91% in 2023. A negative growth of 18.38% was recorded in its total assets. In 2023, Farmacos Centrales Globales S.A. DE C.V.’s net profit margin decreased by 9.57%.

Headquarters
Av. Del 57 84, Col. Centro
Queretaro; Queretaro; Postal Code: 76000

Contact Details: Purchase the Farmacos Centrales Globales S.A. DE C.V. report to view the information.

Basic Information
Total Employees:
Purchase the Farmacos Centrales Globales S.A. DE C.V. report to view the information.
Outstanding Shares:
Purchase the Farmacos Centrales Globales S.A. DE C.V. report to view the information.
Incorporation Date:
November 11, 2014
Key Executives
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Farmacos Centrales Globales S.A. DE C.V. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MXN. Absolute financial data is included in the purchased report.
Net sales revenue
10.91%
Total operating revenue
10.91%
Operating profit (EBIT)
-56.2%
Net Profit (Loss) for the Period
-56.2%
Total assets
-18.38%
Total equity
23.62%
Operating Profit Margin (ROS)
-9.57%
Net Profit Margin
-9.57%
Return on Equity (ROE)
-34.82%
Debt to Equity Ratio
-43.91%
Quick Ratio
7.02%
Cash Ratio
5.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?